KLOW
$109.99
Out of StockKLOW is a four-component capsule blend containing KPV, BPC-157, TB-500, and MOTS-c for exploratory laboratory research across inflammatory, tissue, mitochondrial, and peptide-signaling models.
| SKU | RC-EX-KLOW-60CT |
|---|---|
| Manufacturer | Exodus |
| Form | Capsule |
| Strength | 500 mcg (KPV), 500 mcg (BPC-157), 2 mg (TB-500), 2 mg (MOTS-c) |
| Size | 60 ct |
| Reported Result | Pending COA |
| Stock | Out of Stock |
| Documentation Status | Pending COA |
Product Description
KLOW combines 500 mcg KPV, 500 mcg BPC-157, 2 mg TB-500, and 2 mg MOTS-c per labeled serving in a 60-capsule Exodus presentation. The components span distinct research areas: KPV is an alpha-MSH-derived tripeptide studied mainly in preclinical inflammatory and epithelial models; BPC-157 is studied in tissue and gastrointestinal models; TB-500 requires sequence verification and is associated with thymosin-beta-4-related research; and MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling. There is no established evidence for the exact branded combination, oral bioavailability, or synergistic effect.
Storage and handling: Store capsules tightly sealed in a cool, dry location protected from heat, light, and moisture, unless the manufacturer specifies otherwise. Use the lot-specific COA/SDS for exact requirements.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| RC-SUP-TEMP-0526 | Lot documentation | Pending | Pending | Lot Documentation | Lot Documentation |
.png)